Photo from Envato
Its growth is attributed to a rise in cancer and cardiovascular diseases.
The global radiopharmaceuticals market is projected to reach $12.2b by 2030 at a compound annual growth rate of 10.3%, according to Research and Markets.
The sector’s expansion is attributed to the rising prevalence of cancer and cardiovascular diseases, developments in imaging technology, and a shift toward personalised medicine.
“Advanced imaging technologies like PET and SPECT improve diagnostic precision, whilst the incorporation of AI enhances the analysis of imaging results,” the report said.
Meanwhile, the growing elderly population and the increasing use of theranostics further contribute to market growth.
Support from government entities, increased investment in research and development, and favourable regulatory approvals drive innovation and help resolve supply chain challenges associated with short-lived radioisotopes.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
